SERCAN KİREMİTÇİ

Dr. SERCAN KİREMİTÇİ

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2022 in Pancreatology
Verified
Journal Article
Closed access
AİAli Tüzün İnce
Ali Tüzün İnce
GSGülseren Seven
Gülseren Seven
KKKoray Koçhan
Koray Koçhan
SKSERCAN KİREMİTÇİ
SERCAN KİREMİTÇİ
KYKemal Yıldız
Kemal Yıldız
HŞHakan Şentürk
Hakan Şentürk

1 March 2025 in Endoscopic Ultrasound
Verified
Journal Article
Open access
SKSERCAN KİREMİTÇİ
SERCAN KİREMİTÇİ
GSGulseren Seven
Gulseren Seven
Gokhan SILAHTAROGLUGokhan SILAHTAROGLU
Gokhan SILAHTAROGLU
KKKoray Kochan
Koray Kochan
STSerife Degirmencioglu Tosun
Serife Degirmencioglu Tosun
HSHakan Senturk
Hakan Senturk
Background and Objectives: Pancreatic neuroendocrine tumors (pNETs) are relatively rare and consist of 2% of the all pancreatic tumors. Although some of pNETs have a benign, nonprogressive course, some may be progressive and result with metastasis. We aimed to estimate the grade of pNETs by using artificial intelligence (AI) via deep learning (DL) algorithms as indexing to cyto/histopathological classification according to the World Health Organization 2017. Methods: A total of 803 EUS images were collected from 44 patients who had a cyto/histo-pathologically confirmed diagnosis with EUS fine-needle aspiration or biopsy (FNA/B). First, raw EUS images were prepared for processing by AI via DL algorithms, and convolutional neural networks were utilized to train the machine to predict the grades from EUS images. IBM SPSS 25.0 program was used for statistical analyses. Results: Thirty of the 44 patients (68%) were female, with a median age of 61 (range, 16–80) years. pNETs were mostly located in the pancreatic head: 24 cases (55%). Location was the neck in 3 (7%), body in 10 (22%), and tail in 7 (16%) patients. According to EUS-FNA/B results, 27 patients were grade 1 (G1) (61%); 12, grade 2 (G2) (27%); and 5, grade 3 (G3) (12%). In reference to the performance of AI for predicting the pathological grade, sensitivity was 94.29%; specificity, 97.14%; and accuracy, 96.19%. When the patient groups were subanalyzed as G1, G2, and G3 by the AI model to predict the pathological grade, the accuracy was as follows: for G1, 93.15%; for G2, 91.61%; and for G3, 98.05%. Conclusions: This pilot study suggests that pNET grade prediction can be reliably done on EUS images using AI-based technology.

30 March 2024 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
HSHakan Sentürk
Hakan Sentürk
İKİbrahim Hakkı Köker
İbrahim Hakkı Köker
KKKoray Koçhan
Koray Koçhan
SKSERCAN KİREMİTÇİ
SERCAN KİREMİTÇİ
GSGülseren Seven
Gülseren Seven
AİAli Tüzün İnce
Ali Tüzün İnce
Background/Aims: Endoscopic ultrasonography-guided gastrojejunostomy is a minimally invasive method for the management of gastric outlet obstruction. Conventionally, a lumen-apposing metal stent (LAMS) is used to create an anastomosis. However, LAMS is expensive and not widely available. In this report, we described a tubular fully covered self-expandable metallic stent (T-FCSEMS) for this purpose.Methods: Twenty-one patients (15 men [71.4%]; median age, 66 years; range, 40–87 years) were included in this study. A total of 19 malignant (12 pancreatic, 6 gastric, and 1 metastatic rectal cancer) and 2 benign cases were observed. The proximal jejunum was punctured with a 19 G needle. The stomach and jejunum walls were dilated with a 6 F cystotome, and a 20×80 mm polytetrafluoroethylene T-FCSEMS (Hilzo) was deployed. Oral feeding was initiated after 12 to 18 hours and solid foods after 48 hours.Results: The median procedure time was 33 minutes (range, 23–55 minutes). After two weeks, 19 patients tolerated oral feeding. In patients with malignancy, the median survival time was 118 days (range, 41–194 days). No serious complications or deaths occurred. All patients with malignancy tolerated oral food intake until they expired.Conclusions: T-FCSEMS is safe and effective. This stent should be considered as an alternative to LAMS for gastric outlet obstruction.

2 January 2024 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
SKSERCAN KİREMİTÇİ
SERCAN KİREMİTÇİ
KKKoray Koçhan
Koray Koçhan
GSGülseren Seven
Gülseren Seven
EKElmas Biberci Keskin
Elmas Biberci Keskin
GOGülay Okay
Gülay Okay
HSHakan Sentürk
Hakan Sentürk
Background/Aims: This study aims to investigate the effects of nucleos(t)ide analogs (NAs) discontinuation in eligible patients in accor dance with the Asian Pacific Association for the Study of the Liver hepatitis B guideline and the factors affecting clinical and virological relapses. Materials and Methods: In this prospectively designed study, hepatitis B e antigen (HBeAg)-negative chronic hepatitis B patients who were followed up between 2012 and 2019 were evaluated and 57 patients were included. All participants enrolled the study were HBeAg negative status at NA initiation. Results: The median age of the patients was 49 (29-72) years and 24 (42%) were females. The median treatment duration was 96 (36 276) months and patients were followed for a median duration of 27 months. Sixteen patients had a previous history of NA switch, and thirteen of these patients had a history of lamivudine resistance. Thirty-eight of 57 patients (66%) developed an elevated hepatitis B virus deoxyribonucleic acid level of >2000 IU/mL at least once, defined as virological relapse and 23 (60%) of them, experienced clinical relapse. Thirty-one of 57 patients were re-treated during the follow-up, and hepatitis B surface antigen (HBsAg) loss occurred among 4 (7%) patients. All patients who experienced HBsAg loss had a history of lamivudine resistance (P = .002). Conclusion: Despite receiving NAs suppression therapy for a long time, HBsAg loss occurs rarely. Although it was not life-threatening, most patients experienced relapses and treatment should be restarted. In our study, whether it is a coincidence that all patients with HBsAg loss are patients in whom NAs are used sequentially due to lamivudine resistance is an issue that needs to be further investigated. Cite this article as: Kiremitçi S, Koçhan K, Seven G, et al. Results of nucleos(t)ide analog treatment discontinuation in hepatitis B e-antigen-negative chronic hepatitis B: NUCSTOP study. Turk J Gastroenterol. 2024;35(1):17-26.

17 March 2020 in European Geriatric Medicine
Verified
Journal Article
Closed access
PDF file
EKElmas Biberci Keskin
Elmas Biberci Keskin
BBBanu Büyükaydın
Banu Büyükaydın
PSPinar Soysal
Pinar Soysal
SKSERCAN KİREMİTÇİ
SERCAN KİREMİTÇİ
AYAyşegül Yabacı
Ayşegül Yabacı
HSHakan Sentürk
Hakan Sentürk

21 November 2025 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
EKElmas Biberci Keskin
Elmas Biberci Keskin
TBTaslidere Bahadir
Taslidere Bahadir
SKSERCAN KİREMİTÇİ
SERCAN KİREMİTÇİ
İKİbrahim Hakkı Köker
İbrahim Hakkı Köker
ÖTÖzlem Toluk
Özlem Toluk
HŞHakan Şentürk
Hakan Şentürk
Background/Aims: Acute pancreatitis is a life-threatening disease associated with significant in-hospital mortality, particularly when complications occur. However, there is little data for long-term all-cause mortality of acute pancreatitis and its relation to etiology. Thus, in this study, both short- and very long-term all-cause mortality after acute pancreatitis were sought. Materials and Methods: Patients admitted with acute pancreatitis to the Bezmialem Vakıf University Hospital from 2012 to 2023 were retrospectively investigated. Demographic and laboratory values were obtained from hospital records. All-cause mortality was assessed using the national death notification system. Results: A total of 689 patients were included in the final analysis. The median follow-up duration was 86 months (range: 0-154 months). The mean age of the study population was 54.3 ± 16.9 years, and 384 individuals (55.7%) were women. The overall in-hospital mortality rate was 2.8%, while 1-year all-cause mortality was 5.4%. Age, diabetes mellitus, and development of in-hospital complications were independent predictors of all-cause long-term mortality. In terms of etiology, alcoholic and hypertriglyceridemia-induced acute pancreatitis had higher in-hospital mortality rates; however, over the long term, alcoholic pancreatitis yielded the worst prognosis. The first year after discharge showed the highest mortality that is most likely associated with in-hospital complications and disease severity. Conclusion: This study sheds light on modern-era mortality rates of acute pancreatitis. Age, diabetes, and in-hospital complication development had a significant impact on long-term survival. Although underrepresented in this cohort, alcoholic pancreatitis had the highest long-term all-cause mortality and clearly represents an issue that deserves to be investigated. Cite this article as: Keskin EB, Taşlıdere B, Kiremitçi S, Köker İH, Toluk Ö, Şentürk H. Long-term all-cause mortality after acute pancreatitis: median 7-year follow-up. Turk J Gastroenterol. 2025;36(12):858-865.